Abstract
MOST reported actions of kainate are mediated by AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) receptors1,2. Here we report that, unlike AMPA which stimulates, kainate elicits a dose-dependent decrease in L-glutamate release from rat hippocampal synaptosomes and also depresses glutamatergic synaptic transmission. Brief exposure to kainate inhibited Ca2+ -dependent [3H] L-glutamate release by up to 80%. Inhibition was reversed by kainate antagonists but not by the AMPA-selective non-competitive antagonist l-(4-aminophenyl)-4-methyl-7,8-methyl-enedioxy-5H-2,3-benzodiazepine (GYKI 52466)3–7. A corresponding reversible kainate-evoked depression of NMDA (N-methyl-D-aspartate) receptor-mediated excitatory postsynaptic currents (e.p.s.cs) was observed when AMPA receptors were blocked by GYKI 52466. The synaptic depression was preceded by a brief period of enhanced release and a small inward current was also observed. The effects of kainate were unaffected by metabotropic glutamate (mGlu), GABAA, GABA B, glycine and adenosine receptor antagonists. These results indicate that glutamate release can be modulated directly by kainate autoreceptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Patneau, D. K. & Mayer, M. L. Neuron 6, 785–798 (1991).
Bettler, B. & Mulle, C. Neuropharmacology 34, 123–139 (1995).
Tarnawa, I., Engeberg, I. & Flatman, J. A. in Amino Acids, Chemistry, Biology and Medicine (eds Lubec, G. & Rosenthal, G. A.) 538–546 (ESCOM, Leiden, Netherlands, 1990).
Palmer, A. J. & Lodge, D. Eur. J. Pharmac. molec. Pharm. Sec. 244, 193–194 (1993).
Donevan, S. D. & Rogawski, M. A. Neuron 10, 51–59 (1993).
Zorumski, C. F., Yamada, K. A., Price, M. D. & Olney, J. W. Neuron 10, 61–67 (1993).
Paternain, A. V., Morales, M. & Lerma, J. Neuron 14, 185–189 (1995).
Barnes, J. M., Dev, K. K. & Henley, J. M. Br. J. Pharmac. 113, 339–341 (1994).
Johansen, T. H., Drejer, J., Watjen, F. & Nielsen, E. Ø. Eur. J. Pharmac. molec. Pharm. Sec. 246, 195–204 (1993).
Verdoorn, T. A., Johansen, T. H., Drejer, J. & Nielsen, E. Ø. Eur. J. Pharmac. molec. Pharm. Sec. 269, 43–49 (1994).
Honoré, T. et al. Science 241, 701–703 (1988).
Sheardown, M. J., Nielsen, E. Ø., Hansen, A. J., Jacobsen, P. & Honoré, T. Science 247, 571–574 (1990).
Wong, L. A. & Mayer, M. L. Molec. Pharmac. 44, 504–510 (1993).
Martin, D., Bustos, G. A., Bowe, M. A., Bray, S. D. & Nadler, J. V. J. Neurochem. 56, 1647–1655 (1991).
Zhou, M., Peterson, C. L., Lu, Y.-B. & Nadler, J. V. J. Neurochem. 64, 1556–1566 (1995).
Collingridge, G. L. & Watkins, J. C. (eds) The NMDA Receptor (Oxford Univ. Press, 1994).
Forsythe, I. D. & Clements, J. D. J. Physiol., Lond. 429, 1–16 (1990).
Collingridge, G. L., Kehl, S. J. & McLennan, H. J. Physiol., Lond. 334, 33–46 (1983).
Legendre, P., Rosenmund, C. & Westbrook, G. L. J. Neurosci. 13, 674–684 (1993).
Bahn, S., Volk, B. & Wisden, W. J. Neurosci. 14, 5525–5547 (1994).
Agrawal, S. G. & Evans, R. H. Br. J. Pharmac. 87, 345–355 (1986).
Sawada, S., Higashima, M. & Yamamoto, C. Expl Brain Res. 60, 323–329 (1985).
Nistri, A. & Cherubini, E. J. Physiol., Lond. 435, 465–481 (1991).
Malva, J. O. et al. Neurosci. Lett. 185, 83–86 (1995).
Lerma, J., Paternain, A. V., Naranjo, J. R. & Mellström, B. Proc. natn. Acad. Sci. U.S.A. 90, 11688–11692 (1993).
Ruano, D., Lambolez, B., Rossier, J., Paternain, A. V. & Lerma, J. Neuron 14, 1009–1017 (1995).
Zeman, S. & Lodge, D. Br. J. Pharmac. 106, 367–372 (1992).
Huettner, J. E. Neuron 5, 255–266 (1990).
Renard, A., Crepel, F. & Audinat, E. Neuropharmacology 34, 335–347 (1995).
Egebjerg, J., Bettler, B., Hermans-Borgmeyer, I. & Heinemann, S. Nature 351, 745–748 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chittajallu, R., Vignes, M., Dev, K. et al. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379, 78–81 (1996). https://doi.org/10.1038/379078a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/379078a0
This article is cited by
-
Exciting Times: New Advances Towards Understanding the Regulation and Roles of Kainate Receptors
Neurochemical Research (2019)
-
Gβγ SNARE Interactions and Their Behavioral Effects
Neurochemical Research (2019)
-
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
BMC Neuroscience (2016)
-
Kainate receptor activation induces glycine receptor endocytosis through PKC deSUMOylation
Nature Communications (2014)
-
Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo
Neurotoxicity Research (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.